Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, Forrest JB, Gordon B, Gray M, Mayer RD, et al
Four capsules daily with water
Equillium (NASDAQ: EQ) shares plummeted 38% from $1.38 to 86 cents Thursday after the company said collaboration partner Ono Pharmaceutical let lapse its option to acquire Equilliums rights to itolizumab, a monoclonal antibody targeting the CD6-ALCAM signaling pathway, which plays a key role in modulating effector T cells that drive numerous immuno-inflammatory diseases
Bhagwanpur, Barwala Road, Derabassi, Punjab 140507, India Manufacturing Unit-2 United Laboratories Nepal Pvt
Dresler T, Caratozzolo S, Guldolf K, Huhn J-I, Loiacono C, Niiberg-Pikkst T, et al
on The Joe Rogan Experience